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Abstract
Introduction Nonfocal transient neurological attacks (TNAs) are associated with an increased risk of future dementia, but it 
is unclear whether TNAs are also associated with concurrent cognitive impairment. We hypothesized that recent TNAs are 
related to worse cognitive functioning. We tested our hypothesis in patients with heart failure, as these patients are at risk 
of cerebral hypoperfusion, which might play a role in the etiology of TNAs.
Methods We performed neuropsychological testing in all patients with heart failure enrolled in the Heart Brain Connec-
tion study. We assessed global cognition, attention-psychomotor speed, executive functioning, memory and language. All 
patients were interviewed with a standardized questionnaire on the occurrence of TNAs in the preceding 6 months. We 
studied associations between TNAs and cognitive functioning with linear and logistic regression analyses, adjusted for age, 
sex and education. We performed additional analyses in patients without previous stroke or TIA and in patients without 
brain infarction on MRI.
Results Thirty-seven (23%) of 158 patients (mean age 70 years, 67% men) experienced one or more TNAs. Patients with a 
recent TNA were more likely to be impaired on ≥ 1 cognitive domains than patients without TNAs [41% vs. 18%, adjusted 
odds ratio 4.6, 95% confidence interval (CI) 1.8–11.8]. Patients with TNAs performed worse than patients without TNAs 
on global cognition (mean difference in z scores − 0.36, 95% CI − 0.54 to − 0.18), and on the cognitive domains attention-
psychomotor speed (mean difference − 0.40, 95% CI − 0.66 to − 0.14), memory (mean difference − 0.57, 95% CI − 0.98 to 
− 0.15) and language (mean difference − 0.47, 95% CI − 0.79 to − 0.16). These associations were independent of cardiac 
output and volume of white matter hyperintensities. Subgroup analyses in patients without previous stroke or TIA or brain 
infarction on MRI (n = 78) yielded comparable results, with the exception of the cognitive domain language, which was no 
longer different between patients with and without TNAs.
Conclusion Among patients with heart failure, TNAs are associated with cognitive impairment, which warrants the need 
for more clinical awareness of this problem.
Keywords Cognitive functioning · Cognitive impairment · Transient neurological attacks · Heart failure
Introduction
Nonfocal transient neurological attacks (TNAs) are char-
acterized by an acute onset of neurological deficits, such 
as unsteadiness, confusion or bilateral weakness [1, 2]. 
In contrast to transient ischemic attacks (TIAs), the signs 
and symptoms of TNAs cannot be attributed to one spe-
cific arterial territory of the brain [3]. TNAs are asso-
ciated with an increased risk of stroke, coronary artery 
disease and dementia [2, 4, 5]. Given this increased risk of 
future dementia, TNAs might be associated with concur-
rent cognitive impairment, despite the fact that signs and 
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symptoms of TNAs are by definition transient. The rela-
tion between TNAs and concurrent cognitive impairment, 
however, has never been investigated.
The etiology of TNAs is unknown, but cerebral hypop-
erfusion, with or without ischemic damage of the brain, 
has been described as an important causal factor [1, 5]. 
Patients with heart failure are at risk of cerebral hypoper-
fusion, which is thought to be mediated through a reduced 
cardiac output, and related to the NYHA classification and 
duration of heart failure [6–8]. Besides cerebral hypoper-
fusion, these patients are also known to be at increased 
risk of cognitive impairment [9, 10]. We, therefore, inves-
tigated the relation between TNAs and cognitive function-
ing in patients with heart failure. We hypothesized that, in 
these patients, a recent TNA is related to worse cognitive 
functioning through a compromised cardiac output. We 
performed additional analyses in patients without a history 
of stroke or TIA, and in patients without brain infarction 
on magnetic resonance imaging (MRI), as these factors 
may independently influence cognitive functioning.
Methods
Study population and design
Between September 2015 and August 2018, patients with 
heart failure were recruited from four cardiology outpa-
tient clinics in the Netherlands [11]. The inclusion crite-
rion was an established diagnosis of heart failure that had 
been clinically stable for at least 6 months. Heart failure 
was defined according to the European Cardiology Society 
Guidelines as both signs and symptoms typical of heart 
failure with objective evidence of a structural or functional 
abnormality of the heart at rest on routine echocardiog-
raphy [12]. All patients were independent in daily living 
and were able to undergo cognitive testing and magnetic 
resonance imaging (MRI) of the brain. Those with a his-
tory of dementia or with a Mini Mental State Examina-
tion (MMSE) < 24 were excluded. Other exclusion criteria 
were: a life expectancy less than 3 years unrelated to heart 
failure, atrial fibrillation at the time of inclusion, prema-
ture ventricular contractions exceeding 10% of the total 
number of heart beats, and a neurological or psychiatric 
diagnosis affecting cognitive functioning (e.g. Parkinson’s 
disease or substance abuse).
The current study is embedded in the Heart Brain 
Connection (HBC) study, a multicenter cohort study that 
focusses on the cardiovascular and hemodynamic contribu-
tions to cognitive impairment. Detailed information on the 
rationale and design has been described elsewhere [11]. The 
HBC study was approved by the ethics committee at the 
Leiden University Medical Center. All participants provided 
written informed consent.
Classification of TNAs
All participants were interviewed by a trained physician 
or research nurse with a standardized questionnaire on the 
occurrence of eight nonfocal symptoms in the preceding 
6 months (Table 1). TNAs were defined as attacks with one 
or more nonfocal signs or symptoms with an acute onset, a 
minimum duration of 30 s and a maximum duration of 24 h. 
Symptoms that were compatible with a different diagnosis, 
such as migraine or epilepsy, were excluded from the analy-
sis. The interviewer was blinded to the neuropsychological 
test scores.
Neuropsychological assessment
Cognitive functioning was assessed in detail with an exten-
sive and standardized neuropsychological test battery that 
was based on the Dutch Parelsnoer Initiative [13]. The 
MMSE [14] was used as a screening instrument. Memory 
was assessed with the Rey Auditory Verbal Learning Test 
(RAVLT) [15] total immediate recall, RAVLT delayed 
recall, RAVLT recognition and the Visual Association Test 
(VAT) [16] (short version). Language was assessed with the 
VAT (naming) and the 1-min animal fluency [17, 18]. The 
Trail Making Test (TMT) [19] part A, Stroop Color Word 
Test (SCWT) [20–22] I and II, Letter Digit Substitution 
Test [23] and Digit span [24] forward were used to assess 
attention and psychomotor speed. Executive functioning 
was assessed with the TMT B/A index, SCWT interference 
and Digit span backward. Global cognitive functioning was 
calculated by combining the compound z scores of all four 
cognitive domains. Patients’ performances on all individ-
ual neuropsychological tests were compared with a refer-
ence group that consisted of 128 people that were recruited 
among spouses and relatives of patients [11]. The reference 
Table 1  Predefined nonfocal 
neurological symptoms
All symptoms should have an 
acute onset, a minimum dura-
tion of 30  s and a maximum 
duration of 24 h
Unconsciousness
Confusion
Amnesia
Unsteadiness
Bilateral leg weakness
Blurred vision
Nonrotatory dizziness
Paresthesias
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group was free from heart failure, and the same exclusion 
criteria as for heart failure patients were applied.
Brain imaging
MRI of the brain was performed on 3T scanners (Philips 
Ingenia, Philips Achieva and Philips Gemini; Philips Medi-
cal Systems, Best, the Netherlands). We acquired T1-, T2- 
weighted and flair-attenuated inversion recovery (FLAIR) 
sequences. A neuroradiologist who was blinded to clinical 
information rated all MRI scans on the presence of brain 
infarction, which was defined as either one or more cortical, 
subcortical or lacunar infarcts. Furthermore, white matter 
hyperintensities of presumed vascular origin were measured 
on FLAIR sequences in milliliters (mL).
Clinical assessment
Cardiac output was assessed with MRI of the heart, left 
ventricular ejection fraction was assessed by echocardiogra-
phy, and duration of heart failure was derived from medical 
records. We assessed age, sex, level of education, NYHA 
classification (divided in seven categories from class I to 
IV), smoking status, a history of myocardial infarction, 
peripheral arterial occlusive disease, TIA, ischemic stroke, 
hypertension and the presence of diabetes mellitus, chronic 
obstructive pulmonary disease (COPD), obstructive sleep 
apnea syndrome (OSAS) and the use of antihypertensive 
or lipid-lowering medication by means of a standardized 
interview. Systolic and diastolic blood pressures were meas-
ured during the study visit on the left and right arm with an 
automatic oscillometric BP monitor; the mean of these two 
readings was used for analyses.
Statistical analysis
Descriptive analyses characterize the study population of 
heart failure patients with and without TNAs. Differences 
were determined with independent sample t tests, Chi square 
tests or Fisher exact tests when appropriate.
All neuropsychological test scores were standardized into 
individual z scores using the mean and standard deviation 
(SD) of control participants of the HBC study as a reference 
group. Individual z scores of each test were subsequently 
combined into cognitive domains. Global cognitive func-
tioning was calculated as the mean z score of all cognitive 
domains. We considered a cognitive domain as impaired 
when the z score was below − 1.5 of the reference group, 
which was further dichotomized into impairment of ≥ 1 and 
≥ 2 cognitive domains.
We used linear regression analyses with the presence of 
TNAs as independent variable and z scores of each cognitive 
domain as well as global cognition as dependent variable 
(separate analyses for each cognitive domain and global 
cognition). We used logistic regression analysis to study 
the association between TNAs and cognitive impairment 
(separate analyses for impairment of ≥ 1 and ≥ 2 cognitive 
domains). In both analyses, we performed three different 
adjustments. First, we adjusted for age, sex and education. 
Second, we additionally adjusted for volume of white matter 
hyperintensities on MRI (in milliliters, mL). Third, addi-
tional adjustments were made for cardiac output.
Subgroup analyses were performed after excluding 
patients with a history of stroke or TIA or patients with brain 
infarction on MRI.
All analyses were done with IBM SPSS Statistics version 
24.0 (IBM Corp, Armonk, NY).
Results
A total of 162 patients with heart failure were included in the 
HBC study. After exclusion of three patients with missing 
questionnaires on nonfocal symptoms and one patient with 
missing neuropsychological test scores, 158 patients [mean 
age 69.7 years (SD 9.8), 67% men] remained for analyses. 
Characteristics of the study population are described in 
Table 2. Thirty-seven patients (23%) had experienced one or 
more TNAs in the preceding 6 months. Patients with TNAs 
more often had a history of TIA than patients without TNAs 
(P = 0.025). Patients with and without TNAs were compara-
ble in age, sex, educational level and presence of hyperten-
sion. Furthermore, cardiac output, left ventricular ejection 
fraction, duration of heart failure and NYHA classification 
did not differ between patients with and without TNAs.
Table 3 shows the z scores of each cognitive domain for 
patients with and without TNAs. Patients with TNAs per-
formed significantly worse than patients without TNAs on 
global cognition, language, memory and attention-psycho-
motor speed, but not on executive functioning. Impairment 
of ≥ 1 cognitive domains was more frequent in patients with 
than in patients without TNAs [41% vs. 18%; adjusted odds 
ratio (OR) 4.6, 95% confidence interval (CI) 1.8–11.8]. 
Impairment of ≥ 2 cognitive domains was also more frequent 
in patients with TNAs than in patients without TNAs (19% 
vs. 4%; adjusted OR 10.4, 95% CI 2.4–45.5) (Table 4). Addi-
tional adjustments for volume of white matte hyperintensi-
ties (mL) (Tables 3, 4) and for cardiac output (Supplemental 
Tables 1 and 2) did not influence these results.
Twenty-three patients (15%) had a previous stroke or 
TIA, and 73 patients (46%) had visible brain infarction on 
MRI. Subgroup analyses in patients without brain infarc-
tion on MRI or previous stroke or TIA (Tables 5, 6, Sup-
plemental Tables 3 and 4) yielded comparable results, with 
the exception of the cognitive domain language, in which 
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there was no longer a difference between patients with and 
without TNAs.
Discussion
Patients with heart failure who had a recent TNA had a 
higher risk of impairment in ≥ 1 and ≥ 2 cognitive domains 
than similar patients without TNAs. This difference con-
cerned global cognition, as well as the cognitive domains 
language, memory and attention-psychomotor speed. The 
results were not influenced by cardiac output or volume of 
white matter hyperintensities. Subgroup analyses in patients 
without brain infarction on MRI or previous stroke or TIA 
yielded comparable results, with the exception of the cogni-
tive domain language.
To the best of our knowledge, this is the first study 
addressing cognitive functioning after a TNA. Subjective 
cognitive complaints, as measured by the Cognitive Fail-
ures Questionnaire, have been investigated in patients who 
had a TIA or TNA [25]. Six months after the initial event, 
77% of these patients experienced subjective cognitive com-
plaints [25]. The authors did not provide separate results 
after TNA only, but they stated that subjective cognitive 
Table 2  Baseline characteristics
Numbers are n (%) or mean ± standard deviation
TNA nonfocal transient neurological attack, Q1–Q3 interquartile range, COPD chronic obstructive pul-
monary disease, OSAS obstructive sleep apnea syndrome, TIA transient ischemic attack, PAOD peripheral 
arterial occlusive disease, LVEF left ventricular ejection fraction, NYHA New York Heart Association
No TNA (n = 121) ≥ 1 TNA (n = 37) P value
Male 85 (70) 21 (57) 0.126
Age (years) 70.0 ± 10.0 68.5 ± 9.0 0.395
Education, median (Q1–Q3) 5 (4-6) 5 (4-6) 0.560
Smoking status 0.789
 Current 17 (15) 5 (14)
 Former 68 (56) 23 (62)
 Never 36 (29) 9 (24)
Hypertension 65 (54) 20 (56) 0.846
Antihypertensive medication 95 (83) 27 (75) 0.312
Lipid-lowering medication 73 (63) 22 (59) 0.705
Diabetes mellitus 22 (19) 3 (8) 0.138
COPD 13 (11) 4 (11) 0.946
OSAS 13 (11) 7 (19) 0.191
History
 Myocardial infarction 60 (50) 20 (54) 0.634
 TIA 8 (7) 7 (19) 0.025
 Ischemic stroke 6 (5) 3 (8) 0.469
 PAOD 6 (5) 2 (5) 0.914
Blood pressure (mmHg)
 Systolic 134 ± 19 135 ± 15 0.856
 Diastolic 76 ± 10 77 ± 13 0.769
LVEF (%) 43 ± 8 44 ± 10 0.616
Cardiac output (L/min) 5.3 ± 1.2 5.2 ± 1.2 0.375
NYHA classification 0.655
 Class I 56 (46) 12 (32)
 Class I–II 20 (16) 7 (19)
 Class II 33 (27) 14 (38)
 Class II–III 6 (5) 2 (5)
 Class III 6 (5) 2 (5)
Duration of heart failure 0.419
 <1 year 6 (5) 1 (3)
 1–5 years 57 (47) 24 (65)
 ≥ 5 years 57 (47) 12 (32)
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Table 3  z scores per cognitive domain and results from the linear regression analysis of the association of TNA with z scores of cognitive func-
tioning
TNA nonfocal transient neurological attack, SD standard deviation, mean difference, the mean difference in z score of cognitive performance 
for ≥ 1 vs. no TNA, CI confidence interval
a Adjusted for age, sex and education
b Adjusted for age, sex, education and white matter hyperintensities volume (mL)
No TNA (n = 121) ≥ 1 TNA (n = 37) Mean difference (95% CI)a P value Mean difference (95% CI)b P value
Mean ± SD
z score
Mean ± SD
z score
Global cognition − 0.30 ± 0.6 − 0.64 ± 0.6 − 0.36 (− 0.54 to − 0.18) 0.000 − 0.39 (− 0.57 to − 0.20) 0.000
Cognitive domain
 Attention-psychomotor 
speed
− 0.39 ± 0.8 − 0.79 ± 0.9 − 0.40 (− 0.66 to − 0.14) 0.003 − 0.44 (− 0.72 to − 0.16) 0.002
 Language − 0.27 ± 0.7 − 0.75 ± 1.3 − 0.47 (− 0.79 to − 0.16) 0.003 − 0.30 (− 0.58 to − 0.01) 0.041
 Memory − 0.33 ± 1.2 − 0.80 ± 1.3 − 0.57 (− 0.98 to − 0.15) 0.008 − 0.73 (-1.15 to − 0.31) 0.001
Executive functioning − 0.22 ± 0.8 − 0.22 ± 0.8 − 0.01 (− 0.27 to 0.26) 0.953 − 0.08 (− 0.36 to 0.21) 0.594
Table 4  Odds ratios for cognitive impairment within 6 months after TNA compared with patients without TNA
Numbers are n (%) unless stated otherwise
Cognitive impairment defined as domain z score < − 1.5
OR odds ratio, CI confidence interval, TNA nonfocal transient neurological attack
a Adjusted for age, sex and education
b Adjusted for age, sex, education and white matter hyperintensities volume (mL)
No TNA (n = 121) ≥ 1 TNA (n = 37) Cognitive impairment, 
OR (95% CI)  adjusteda
P value Cognitive impairment, 
OR (95% CI)  adjustedb
P value
≥ 1 Cognitive domains 22 (18) 15 (41) 4.6 (1.8–11.8) 0.002 5.3 (1.9–14.4) 0.001
≥ 2 Cognitive domains 5 (4) 7 (19) 10.4 (2.4–45.5) 0.002 14.1 (2.8–71.9) 0.001
Table 5  Sensitivity analysis in patients without previous stroke or TIA and without brain infarction on MRI (n = 78)
z scores per cognitive domain and results from the linear regression analysis of the association of TNA with z scores of cognitive functioning
TNA nonfocal transient neurological attack, SD standard deviation, mean difference the mean difference in z score of cognitive performance 
for ≥ 1 vs. no TNA, CI confidence interval
a Adjusted for age, sex and education
b Adjusted for age, sex, education and white matter hyperintensities volume (mL)
No TNA (n = 62) ≥ 1 TNA (n = 16) Mean difference (95% CI)a P value Mean difference (95% CI)b P value
Mean ± SD
z score
Mean ± SD
z score
Global cognition − 0.14 ± 0.6 − 0.62 ± 0.7 − 0.36 (− 0.59 to − 0.12) 0.004 − 0.35 (− 0.59 to − 0.12) 0.004
Cognitive domain
 Attention-psychomotor 
speed
− 0.21 ± 0.7 − 0.92 ± 1.1 − 0.51 (− 0.87 to − 0.15) 0.006 − 0.51 (− 0.87 to − 0.15) 0.006
 Language − 0.27 ± 0.8 − 0.45 ± 0.4 − 0.04 (− 0.45 to 0.38) 0.865 − 0.33 (− 0.45 to 0.38) 0.876
 Memory − 0.09 ± 0.9 − 0.84 ± 1.5 − 0.68 (− 1.25 to − 0.11) 0.020 − 0.68 (− 1.25 to − 0.11) 0.021
Executive functioning − 0.01 ± 0.6 − 0.27 ± 0.8 − 0.20 (− 0.53 to 0.13) 0.238 − 0.20 (− 0.53 to 0.14) 0.243
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complaints were the same in patients diagnosed with a 
TNA as in patients with a TIA [25]. Another study investi-
gated the 6-month course of cognitive functioning after both 
TIA and TNA combined, in relation to diffusion weighted 
imaging (DWI) results at baseline [26]. Patients with a 
DWI lesion had worse executive function at baseline than 
those without a DWI lesion, which persisted throughout the 
6-month study period [26]. The authors mentioned that the 
clinical diagnosis (TIA or TNA) was not related to cognitive 
functioning at baseline or over time, even though numbers 
were not provided separately for patients with a TNA only 
[26]. Although the above-described studies have a different 
design, the results seem to concur with our findings [25, 26].
There are several mechanisms that may describe the rela-
tion between a recent TNA and cognitive impairment. First, 
as TNAs and cognitive impairment share some of the same 
risk factors, they may result from the same underlying dis-
ease process [1, 27, 28]. Nevertheless, in our study sample, 
patients with TNAs were not more likely to have vascular 
risk factors, such as hypertension, lipid-lowering medica-
tion or diabetes mellitus than participants without TNAs. 
Second, cognitive impairment could be the result of cerebral 
hypoperfusion, which has long been suggested a potential 
cause of TNAs [1, 2, 29]. This concurs with the results of a 
large, population-based study in which cerebral hypoperfu-
sion is associated with accelerated cognitive decline [30]. 
Previous studies in heart failure patients that related the left 
ventricular ejection fraction to cognitive impairment showed 
conflicting results [9, 10, 31]. However, in our study, cardiac 
output, left ventricular ejection fraction and NYHA clas-
sification did not differ between patients with and without 
TNAs, and adjusting for cardiac output did not influence 
our results. Cardiac output may serve as a surrogate for 
the severity of heart failure, and consequently the extent to 
which cerebral perfusion potentially may be compromised 
[6–8, 32, 33]. Therefore, our findings argue against the 
explanation that cognitive impairment in patients with TNAs 
is mediated through cerebral hypoperfusion [6–8, 32, 33].
A third explanation is that, even though TNAs are by 
definition transient, they might lead to permanent brain 
damage. This brain damage could disrupt networks lead-
ing to cerebral atrophy and cognitive impairment [34]. This 
explanation is compatible with the results of previous stud-
ies in which similar signs of acute focal cerebral ischemia, 
as measured by diffusion weighted imaging, were found in 
patients diagnosed with both a recent TIA and recent TNA 
[4, 35]. Our finding that patients with TNAs more often had 
a history of TIA than patients without TNAs supports this 
hypothesis. Still, our results were not substantially influ-
enced after excluding all patients with previous stroke or 
TIA or brain infarction on MRI, which might argue against 
permanent brain injury as the cause of cognitive impairment 
in patients with TNAs. Furthermore, adjusting for volume 
of white matter hyperintensities on MRI did not change our 
results. In conclusion, the exact mechanisms between TNAs 
and cognitive impairment remain unclear.
Our second finding that patients with TNAs perform 
significantly worse than patients without TNAs on global 
cognition, language, memory and attention-psychomotor 
speed, but not on executive functioning is remarkable, as 
we had expected that executive functioning would be the 
most sensitive cognitive domain [26]. There are several 
explanations for this finding. A first possibility is that our 
neurocognitive tests were not sensitive enough to detect 
changes in executive functioning. However, we used neu-
ropsychological tests with international standards (TMT 
B/A index, SCWT III, SCWT interference and Digit span 
backward) to measure executive functioning. Second, we 
intentionally separated executive functioning from atten-
tion/psychomotor speed, while some authors chose to com-
bine both domains into one cognitive domain [36].
Certain limitations of our study have to be considered. 
First, as this is a cross-sectional study, we cannot draw 
conclusions on causality. Second, the diagnosis of a TNA 
is made only on the basis of self-report and we may either 
have misclassified episodes as TNAs or missed TNAs that 
were not remembered by the patient, leading to recall bias. 
Table 6  Sensitivity analysis in patients without previous stroke or TIA and without brain infarction on MRI (n = 78)
Odds ratios for cognitive impairment within 6 months after TNA compared with patients without TNA
Numbers are n (%) unless stated otherwise
Cognitive impairment defined as domain z score < − 1.5
OR odds ratio, CI confidence interval, TNA nonfocal transient neurological attack
a Adjusted for age, sex and education
b Adjusted for age, sex, education and white matter hyperintensities volume (mL)
No TNA (n = 62) ≥ 1 TNA (n = 16) Cognitive impairment, 
OR (95% CI)  adjusteda
P value Cognitive impairment, 
OR (95% CI)  adjustedb
P value
≥ 1 Cognitive domains 6 (10) 6 (38) 5.8 (1.1–29.9) 0.035 5.8 (1.1–29.7) 0.036
≥ 2 Cognitive domains 1 (2) 3 (19) 16.6 (1.1–253.8) 0.044 19.3 (1.1–354.5) 0.046
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However, we used a standardized questionnaire, system-
atically assessed by a trained physician or research nurse, 
which covered all types of TNAs we were interested in. 
Third, as we studied patients with heart failure, the gen-
eralizability to a broader group of patients with TNAs 
is limited. However, our patient population was chosen 
deliberately, as patients with heart failure may be vulner-
able for cerebral hypoperfusion through a compromised 
cardiac output. Most patients with heart failure had NYHA 
class I or I–II, indicating they had only mild heart failure, 
which might implicate that our results are not generaliz-
able to patients with severe heart failure. Last, we have no 
information regarding the functional impact of cognitive 
problems on the daily living in patients with TNAs or on 
subjective memory complaints before and after the TNA.
One of the strengths of our study is that we conducted 
a comprehensive neuropsychological test battery com-
posed of tests with international standards, administered 
by trained neuropsychologists. Therefore, we were able to 
draw conclusions on domain-specific cognitive function-
ing. A novelty of this study is that we focused on patients 
diagnosed with TNAs only, instead of patients diagnosed 
with TNAs and TIAs combined. Of note, a TNA is not 
a specific clinical diagnosis, but rather an entity that 
includes many different symptoms. It is a concept that 
is used to describe those patients that are clinically not 
diagnosed as having had a TIA [3]. Although they are tra-
ditionally seen as a benign event, they are associated with 
an increased risk of future vascular events and dementia 
[2, 4, 5]. Our results further emphasize the need to change 
this widely accepted benign concept of TNAs into a more 
hazardous event.
In conclusion, among patients with heart failure, TNAs 
are related to cognitive impairment. This highlights the 
need for more clinical awareness of both TNAs and cogni-
tive impairment in heart failure patients. Future studies are 
needed to unravel the mechanisms leading to the association 
between cognitive impairment and TNAs, and to determine 
the effect of therapeutic intervention. These studies should 
be longitudinal and include advanced brain imaging tech-
niques to identify ischemic, microstructural and perfusion 
changes.
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